42 results
424B5
CNTA
Centessa Pharmaceuticals plc
13 Sep 24
Prospectus supplement for primary offering
4:02pm
disorder that affects the brain’s ability to regulate the normal sleep-wake cycle. Narcolepsy is classified as two subtypes, NT1 and NT2. NT1 is caused … ;
tax-exempt entities or government organizations;
S corporations, partnerships, or other entities or arrangements classified as partnerships for U.S
424B5
CNTA
Centessa Pharmaceuticals plc
11 Sep 24
Prospectus supplement for primary offering
4:40pm
is classified as two subtypes, NT1 and NT2. NT1 is caused by the profound loss of orexin-producing neurons, resulting in a dramatic reduction of orexin … or government organizations;
S corporations, partnerships, or other entities or arrangements classified as partnerships for U.S. federal income tax
S-3ASR
CNTA
Centessa Pharmaceuticals plc
11 Sep 24
Automatic shelf registration
4:01pm
of directors is classified, stockholders may effect such removal only for cause, or (ii) in the case of a corporation having cumulative voting, if less than
424B5
4crld 2esov
24 Apr 24
Prospectus supplement for primary offering
8:53pm
8-K
cgx75wtf 0f
24 Apr 24
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
9:26am
424B5
z8gk0x5
23 Apr 24
Prospectus supplement for primary offering
5:16pm
S-3
tj5dwwk hj9uc97
1 Jul 22
Shelf registration
4:06pm
10-K
EX-10.35
3hsv wp3rbk18351rx
30 Mar 22
Annual report
12:00am
10-K
g20ytz7b j7xp
30 Mar 22
Annual report
12:00am